These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11103561)

  • 1. [Göppingen 1999 vaccination program in the 5th and 6th grade].
    Oettinger B; Gröber U; Ernst E
    Gesundheitswesen; 2000 Oct; 62(10):505-10. PubMed ID: 11103561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vaccination status and implementation of recommendations for vaccination with special reference to measles-mumps-rubella vaccination. 1995 program for school entrance].
    Ziemer B; Blank K; Hennig R
    Gesundheitswesen; 1998 May; 60(5):297-300. PubMed ID: 9676011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M; Pattison HM
    Br J Gen Pract; 2000 Dec; 50(461):969-71. PubMed ID: 11224968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
    Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sero-response to measles-mumps-rubella vaccine campaign in Saudi Arabia.
    Al-Mazrou YY; Khalil MK; Tumsah S; Al-Ghamdi YS; Al-Jeffri MH; Tischer AB; Mishkhas AA; Eissa M
    Saudi Med J; 2002 Jun; 23(6):680-3. PubMed ID: 12070547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surveillance of measles in Germany].
    Tischer A; Siedler A; Rasch G
    Gesundheitswesen; 2001 Nov; 63(11):703-9. PubMed ID: 11713702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R; Svensson E; Trollfors B; Borres MP
    Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium.
    Theeten H; Vandermeulen C; Roelants M; Hoppenbrouwers K; Depoorter AM; Van Damme P
    Acta Paediatr; 2009 Aug; 98(8):1307-12. PubMed ID: 19432835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the United States.
    Kolasa MS; Klemperer-Johnson S; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S98-103. PubMed ID: 15106097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for undervaccination against measles in a large sample of preschool children from rural Bavaria.
    Zucs AP; Crispin A; Eckl E; Weitkunat R; Schlipköter U
    Infection; 2004 Jun; 32(3):127-33. PubMed ID: 15188070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
    Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
    Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of measles in primary school students with high first dose MMR vaccination coverage.
    Ong G; Rasidah N; Wan S; Cutter J
    Singapore Med J; 2007 Jul; 48(7):656-61. PubMed ID: 17609829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren.
    Roost HP; Gassner M; Grize L; Wüthrich B; Sennhauser FH; Varonier HS; Zimmermann H; Braun-Fahrländer Ch;
    Pediatr Allergy Immunol; 2004 Oct; 15(5):401-7. PubMed ID: 15482514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving 95% uptake in an immunisation programme--not an impossibility.
    Joyce-Cooney J; Meagher G; Quinn C; Cavanagh I
    Ir Med J; 2003 Oct; 96(9):268-70. PubMed ID: 14753580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaccination of young children, at school entrance and completion in the Bern canton 1998].
    Maurer AM; Mühlemann K; Seiler AJ
    Praxis (Bern 1994); 2001 Sep; 90(39):1676-84. PubMed ID: 11680120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement of protection given by vaccination for socially underprivileged groups on the basis of "key persons approach" -- results of an intervention based on cultural and language aspects for children of immigrants in Altlander Viertel provided by the Health Department of Stade].
    Pallasch G; Salman R; Hartwig C
    Gesundheitswesen; 2005 Jan; 67(1):33-8. PubMed ID: 15672304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination coverage in 14-year-old adolescents: documentation, timeliness, and sociodemographic determinants.
    Vandermeulen C; Roelants M; Theeten H; Depoorter AM; Van Damme P; Hoppenbrouwers K
    Pediatrics; 2008 Mar; 121(3):e428-34. PubMed ID: 18310163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.